Chapter 66 On the eve of listing
The working status of company employees is completely different between companies with development prospects and companies without development prospects.
The most important impact of the environment on individuals is that after Guangjia Technology received 1.5 billion in external financing, everyone’s expectations for it changed from an entrepreneurial company to a company with a market value of 10 billion. With the addition of state-owned assets With the background and reputation of the founder, employees are very optimistic and believe that it will be a matter of time before Guangjia Technology goes public.
The Chinese stock market is different from the stock markets in other countries. The difference here is not that the money-making effect is poor. The fundamental difference is that the stock markets in other countries are a barometer of business operations and are intended to help companies do better. survive.
The Huaguo stock market is to help companies survive. As long as you can continue to operate and solve the employment problem, it doesn't matter how you falsify finances, deceive small and medium investors, or maliciously manipulate stock prices. It's nothing more than a high-level board. Raise it and lower it gently, because the fundamental purpose of the Chinese stock market is to help companies survive.
Question makers who will join Guangjia Technology may not be able to sum up this point, but they know very well that if Guangjia Technology is listed, the options will be realized sooner or later.
So the earliest scientific researchers had similar careers. Many of the researchers who later joined Guangjia Technology had their salaries reduced. The salary reduction here means that they received less salary.
Everyone feels that Guangjia Technology has unlimited prospects and is just around the corner.
The prerequisite for listing is that the company must have viable products, and the products must be able to create value for the company. To be listed on the Science and Technology Innovation Board, operating income must exceed 30 million RMB for two consecutive years, and the net profit must be positive. of.
“Boss, the data of this clinical trial is consistent with the experience of the experimenters. As you speculated, there is a deviation between the area we found and the actual area. After a large number of experiments, the current The clinical experiment performance is almost consistent with the results in the experimental monkeys." Song Ming, a doctor who was later recruited, served as Chen Yuanguang's assistant on this project.
A researcher from the Institute of Neurology of the Chinese Academy of Sciences, he had a very high level before joining Guangjia Technology, and his name can be found on Baidu Encyclopedia.
Chen Yuanguang is probably sent by relevant departments to participate in front-line research on human hibernation technology.
Chen Yuanguang didn't mind either. He didn't have the capital to keep all the technology completely confidential. If the relevant departments didn't do the confidentiality work, the information would have been leaked out like a sieve.
So after Song Ming fully demonstrated his abilities, Chen Yuanguang quickly entrusted him with an important task and made him the vice president in charge of research and development.
Chen Yuanguang nodded: "It seems that we will soon enter the second phase of clinical trials."
Chen Yuanguang thought for a while and then said: "I know that many researchers join Guangjia Technology because Guangjia Technology can go public. After all, a large part of the salary we give everyone is option incentives.
Before The person in charge of the issuance of the Science and Technology Innovation Board of CICC came to talk to me. What they meant was that it would be listed on the market after the second phase of clinical trials.” He has also heard about this, "Is the second phase enough? Doesn't it mean that we need operating income and actual profits?
It seems that our current main source of income is government policy subsidies. This should It cannot meet the listing requirements. "
Chen Yuanguang said: "I thought so before. After the people from CICC introduced it to me in detail, I realized that companies like ours can take the fifth path. The market value is not less than 4 billion RMB, and the main business can be listed if it achieves phased results
Companies like those making quantum computers are taking this path.
Because we are in the pharmaceutical industry, at least one core product can be launched on the market after it has started Phase II clinical trials. You just need to start doing it, and you don’t need to finish it. Therefore, after this phase of clinical trials is completed and the next phase is approved, Guangjia Technology can be launched on the market. ”
Before simulating business operations, Chen Yuanguang was not interested in going public at all. He felt that companies should only go public if they have no money. There is no need to go public when a company is doing well. Going public will take away what is in your hands. If the shares are diluted, there will also be the risk of others competing for control.
He only now realizes that the stock market, especially the Chinese stock market, is a place where companies can repeatedly obtain large amounts of low cost. A place for working capital.
You can do private placement, pledge stocks, allot shares, issue convertible bonds, etc.
Compared with borrowing money from banks, the cost of capital in the stock market is even lower.
Therefore, Chen Yuanguang also hopes to list Guangjia Technology as soon as possible. As long as the same shares have different rights, the control of Guangjia Technology will always be firmly in his hands.
“So that’s it. I said that when I was at the Academy of Sciences, I learned about some companies listed on the Science and Technology Innovation Board. I felt that they had no profitability and could be listed.
Those companies have always been listed on the Science and Technology Innovation Board. Dui has a doctorate and a master's degree, and the salary cost should be very high. The demand for the product is very narrow, and it is even a pseudo-concept. The market value has been raised to 100 billion. I guess this is the way it was initially listed. "
Chen Yuanguang's acumen allowed him to quickly guess which company it was, but he did not expand on the topic. "Dr. Song, I will trouble you to complete the first phase of clinical trials later, and then start to compile the experimental data to promote the second phase of clinical trials." "Declaration of the experiment."
Du Nanping usually makes a living by driving online ride-hailing services, mainly Didi, and occasionally runs on other platforms. While driving, he likes to scold unscrupulous platforms for being too exploitative. In addition to his main job, he is also a drug tester. Unlike drug testers who have certain diseases, he is relatively healthy and does not have infectious diseases, heart disease, digestive system diseases, etc. This is a healthy subject.
Working in this business is also about making money quickly. In two cycles, you only need to take medicine and cooperate with examinations, and you can get eight to nine thousand yuan. This money is easy to come by.
Of course there are risks behind the ease, but as an experienced drug tester, Du Nanping has joined many groups related to sharing drug testing information, and he has also participated in so many drug testing work. It is relatively safe, but you have to make your own judgment as to which ones are risky.
“Shenhai tertiary hospital is recruiting drug testers. There are 98 patients enrolled. The screening interval is one day. Tattoos will not be checked. The subsidy amount is 9,000 yuan for men and 9,500 yuan for women. A deposit needs to be paid in advance. Those who are willing Private chat.”
They have to pay a deposit, and the top three companies won’t go.
“Zhangjiang Hi-tech multinational giant recruits drug testers, 327 people are enrolled, and they are required to have complications of diabetes and hypertension, and the subsidy amount is.”
Multinational giant, you need to have diabetes, no go.
"Caohejing Startup Company is recruiting drug testers. The number of enrollees is 500. There is no limit to men and women. Tattoos will not be checked. The subsidy amount is a unified 10,000 yuan. No deposit is required. There are no disease requirements. In a word, just be a human being. , if you are willing to chat privately, first come first served.”
It seems problematic, but why is it so tempting? I'd better chat with him privately and ask, Du Nanping thought to himself.
(End of this chapter)